Pages that link to "Q36020130"

The following pages link to C-type natriuretic peptide in vascular physiology and disease. (Q36020130):

Displaying 38 items.

• Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy (Q28297738) (← links)
• Natriuretic peptide (Q29028296) (← links)
• Protective effects of C-type natriuretic peptide on linear growth and articular cartilage integrity in a mouse model of inflammatory arthritis (Q33667772) (← links)
• Advances in research on and diagnosis and treatment of achondroplasia in China. (Q34377947) (← links)
• Impact of obesity on the expression profile of natriuretic peptide system in a rat experimental model (Q34979675) (← links)
• Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients (Q35566943) (← links)
• Combination of Ca2 -activated K channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery. (Q36054413) (← links)
• Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling (Q36144664) (← links)
• In vitro evaluation of cenderitide-eluting stent I -an antirestenosis and proendothelization approach (Q36206241) (← links)
• In vivo Evaluation of Cenderitide-Eluting Stent (CES) II. (Q36470750) (← links)
• Associations Between Genetic Variants of the Natriuretic Peptide System and Blood Pressure Response to Dietary Sodium Intervention: The GenSalt Study (Q36591776) (← links)
• Serial Evaluation of Abdominal Fluid and Serum Amino-terminal pro-C-type Natriuretic Peptide in Dogs with Septic Peritonitis (Q36873538) (← links)
• Natriuretic peptide C receptor signalling in the heart and vasculature (Q37002318) (← links)
• Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria (Q37071264) (← links)
• Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases. (Q37157505) (← links)
• Myocardium tissue changes caused by electrical transthoracic discharges in rats. (Q37406870) (← links)
• CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease (Q37768079) (← links)
• Biochemistry of the human B-type natriuretic peptide precursor and molecular aspects of its processing (Q37852281) (← links)
• Heart specific up-regulation of genes for B-type and C-type natriuretic peptide receptors in diabetic mice. (Q38316458) (← links)
• Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug (Q38847918) (← links)
• Four peptide hormones' specific decrease (up to 97%) of human prostate carcinoma cells (Q40355020) (← links)
• Constitutively active form of natriuretic peptide receptor 2 ameliorates experimental pulmonary arterial hypertension (Q40649909) (← links)
• Natriuretic Peptide Receptor-C is Up-Regulated in the Intima of Advanced Carotid Artery Atherosclerosis. (Q41672035) (← links)
• Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension. (Q42822789) (← links)
• Blood serum levels of amino-terminal pro-C-type natriuretic peptide in patients with rheumatoid arthritis (Q42863433) (← links)
• Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction (Q44710575) (← links)
• Statins exert endothelial atheroprotective effects via the KLF2 transcription factor (Q46477118) (← links)
• B-type natriuretic peptide decreases gastric emptying and absorption (Q46681492) (← links)
• C-type natriuretic peptide attenuates LPS-induced endothelial activation: involvement of p38, Akt, and NF-κB pathways (Q46856213) (← links)
• Novel Biomarkers for the Risk Stratification of Heart Failure with Preserved Ejection Fraction (Q48156451) (← links)
• Lysophosphatidylcholine increases C-type natriuretic peptide expression in human vascular smooth muscle cells via membrane distortion. (Q51774831) (← links)
• Functional characteristics of mesenchymal stem cells derived from the adipose tissue of a patient with achondroplasia. (Q53126707) (← links)
• Increased circulating bioactive C-type natriuretic peptide is associated with reduced heart rate variability in patients with chronic kidney disease. (Q54969950) (← links)
• Early synergistic interactions between the HPV16‑E7 oncoprotein and 17β-oestradiol for repressing the expression of Granzyme B in a cervical cancer model. (Q55381492) (← links)
• A Micro-Scale Model to Monitor the Major Proteins in Human Urine Before and After Medication with Angiotensin-Converting Enzyme Inhibitor: A Preliminary Study (Q58309332) (← links)
• C-Type Natriuretic Peptide (CNP) Inhibition of Interferon-γ-Mediated Gene Expression in Human Endothelial Cells In Vitro (Q58738761) (← links)
• Serum levels of natriuretic peptides in patients with Behcet's disease (Q81091749) (← links)
• C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels (Q87633379) (← links)